Mitsubishi UFJ Trust & Banking
MD icon

Mitsubishi UFJ Trust & Banking’s Pediatrix Medical MD Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$822K Buy
32,456
+20,739
+177% +$472K ﹤0.01% 910
2026
Q1 		$251K Buy
+11,717
New +$244K ﹤0.01% 1048
2023
Q2 		– Sell
-18,409
Closed -$274K – 1173
2023
Q1 		$274K Buy
18,409
+1,351
+8% +$20.5K ﹤0.01% 975
2022
Q4 		$253K Buy
17,058
+2,385
+16% +$38.9K ﹤0.01% 1015
2022
Q3 		$242K Buy
14,673
+660
+5% +$13.3K ﹤0.01% 997
2022
Q2 		$294K Buy
14,013
+5,090
+57% +$104K ﹤0.01% 994
2022
Q1 		$210K Sell
8,923
-3,200
-26% -$78.3K ﹤0.01% 1197
2021
Q4 		$330K Sell
12,123
-1,897
-14% -$50.8K ﹤0.01% 1174
2021
Q3 		$399K Sell
14,020
-17,100
-55% -$521K ﹤0.01% 1146
2021
Q2 		$949K Sell
31,120
-1,741
-5% -$51.4K ﹤0.01% 944
2021
Q1 		$806K Sell
32,861
-21,239
-39% -$544K ﹤0.01% 916
2020
Q4 		$1.33M Sell
54,100
-7,000
-11% -$131K ﹤0.01% 867
2020
Q3 		$995K Sell
61,100
-10,700
-15% -$199K ﹤0.01% 872
2020
Q2 		$1.23M Buy
71,800
+19,700
+38% +$292K ﹤0.01% 834
2020
Q1 		$606K Hold
52,100
– – ﹤0.01% 910
2019
Q4 		$1.45M Buy
52,100
+20,800
+66% +$522K ﹤0.01% 858
2019
Q3 		$708K Buy
+31,300
New +$713K ﹤0.01% 959
2017
Q4 		– Sell
-204,008
Closed -$8.8M – 811
2017
Q3 		$8.8M Sell
204,008
-1,396
-0.7% -$66.3K 0.02% 675
2017
Q2 		$12.4M Buy
205,404
+20,436
+11% +$1.21M 0.02% 629
2017
Q1 		$12.8M Buy
184,968
+236
+0.1% +$16.4K 0.03% 613
2016
Q4 		$12.3M Sell
184,732
-4,434
-2% -$288K 0.03% 618
2016
Q3 		$12.5M Buy
189,166
+1,156
+0.6% +$79.1K 0.03% 599
2016
Q2 		$13.6M Sell
188,010
-1,235
-0.7% -$84.9K 0.03% 569
2016
Q1 		$12.2M Buy
189,245
+2,337
+1% +$155K 0.03% 594
2015
Q4 		$13.4M Buy
+186,908
New +$13.8M 0.03% 565
2014
Q4 		– Sell
-71,000
Closed -$3.89M – 762
2014
Q3 		$3.89M Buy
+71,000
New +$4.03M 0.01% 679

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's MD Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking increased its Pediatrix Medical (MD) stake by 177% in Q2 2026, buying an estimated $472K and bringing the position to 32,456 shares worth $822K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

Mitsubishi UFJ Trust & Banking first reported a position in MD in Q3 2014 and has held it in 26 quarters since. The position peaked at $13.6M in Q2 2016. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 32,456 shares of Pediatrix Medical worth $822K as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking bought 20,739 Pediatrix Medical shares in Q2 2026, an estimated $472K.
  • Pediatrix Medical made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #910 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Pediatrix Medical in Q3 2014 and has held it in 26 quarters since.
  • Mitsubishi UFJ Trust & Banking's Pediatrix Medical position peaked at $13.6M in Q2 2016.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.